When the PMR values from all 36 patients were used for a Kaplan-Meier analysis we could demonstrate that even the plasma mSHOX2 baseline levels showed a trend toward significance ( Fig. 3 ).
← all excerpts
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
1
—
—